Corporate & Financial Strategy
  Investor Relations
  Financial Communications

EJ Palmer Consulting

Storm Therapeutics

STORM Therapeutics is a pioneer in the field of RNA epigenetics. It is an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

EJPC worked with Storm Therapeutics on establishing its key messages, branding and corporate presentation following its successful Series A fundraising.